alexa
Reach Us +1(850)754-6199
Study Of Mesenchymal Stem Cells From Umbilical Cord Tissue- A Promising Approach To Human Future | 4764
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Study of mesenchymal stem cells from umbilical cord tissue- A promising approach to human future

3rd World Congress on Biotechnology

R. Sangeetha, G. Rajeshwari and M. Subash Chandra Bose

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

Abstract
Research on stem cells is advancing knowledge about how an organism develops from a single cell and how healthy cells develop in adult organisms. This promising area of science is also leading scientist to investigate the possibility of cell based therapies to treat disease, which is often to a regenerative medicine. Stem cells are one of the most fascinating areas of biology today. But like many expanding field of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries. The major sources of stem cells are embryonic and adult stem cells. Embryonic stem cells, as their name suggests, are derived from embryos and the sources of adult stem cells are umbilical cord, menstrual blood, muscle, tendons, adipose tissue, bone marrow etc. Mesenchymal stem cells (MSC) or mesenchymal progenitor cells can be ex vivo expanded and induced, either in vitro or in vivo, terminally differentiate into osteoblasts, chondrocytes, adipocytes, tenocytes, myotubes, neural cells and hematopoietic ? supporting stroma. The multi-potential of these cells, their easy isolation and culture, as well as their high ex vivo expansive potential makes these cells an attractive therapeutic tool. As they are multipotent, they are applied as a promising tool in regenerative medicine and new clinical concepts in supporting cellular theraphy. This leads to the purpose to find an alternative source of Mesenchymal Stem Cells as collection of MSC from bone marrow involves an invasive, painful procedure and low amount of functional, viable MSCs are isolated from the Human Umbilical Cord Blood and thus we are isolating the Adult Mesenchymal Stem Cells from Umblical Cord ant the isolated stem cells are cultured in vitro in culture medium. The isolated stem cells are cryopreserved in liquid Nitrogen vapour which can be retrieved for future studies. The isolated Mesenchymal Stem Cells can be characterized morphologically and also by Flow Cytometry using surface markers like CD90, CD105, CD31, CD34 and the viability is also checked using Tryphan blue. Control assay is performed to detect the presence of Mycoplasma and inorder to avoid the non specific binding of antigen to the antibody, the isotype controls were used in the form of immunoglobulin flourochrome moieties (IgG 1 ?FITC and IgG1-PE). In this study, the isolated cells showed the typical characteristics of mesenchymal stem cells derived from umbilical cord. They were spindle shaped in nature and formed colonies in the primary culture and they resulted positive for CD90 and CD105 markers and negative for markers CD34 and CD31. Thus the isolated Mesenchymal Stem Cells are used for further studies such as differentiation, population doubling, karyotyping, animal studies for clinical trials and make it all the way viable for its use in transplantation procedures for curing the dreadful diseases.
Biography
R. Sangeetha is pursuing her undergraduate in Bachelor of Biotechnology (IVth year) at Rajalakshmi Engineering College affliated to Anna University, Chennai, India. She performed many Paper and Poster Presentations in several National Conferences. She have underwent training in Bioinformatics tools, learnt several techniques related to molecular biology field, Chromatography Techniques (Protein Purification Techniques) and Animal Handling. She had a chance of understanding the techniques & methodologies followed in Pharmaceutical industries. She did piece of work on toxicogenomics & Stem Cells of her guide, M. Subash Chandra Bose.
Top